Evans syndrome after autologous peripheral blood stem cell transplantation for recurrent Hodgkin lymphoma | Zendy

Kato Ikuko | Zendy; Okada Hitoshi | Zendy; Nishida Tomoko | Zendy; Konishi Yukihiko | Zendy; Kondo Sonoko | Zendy; Nishisho Sae | Zendy; Iwase Takashi | Zendy; Itoh Susumu | Zendy; Kusaka Takashi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Evans syndrome after autologous peripheral blood stem cell transplantation for recurrent Hodgkin lymphoma

Author(s) -

Kato Ikuko,

Okada Hitoshi,

Nishida Tomoko,

Konishi Yukihiko,

Kondo Sonoko,

Nishisho Sae,

Iwase Takashi,

Itoh Susumu,

Kusaka Takashi

Publication year - 2016

Publication title -

pediatrics international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.49

H-Index - 63

eISSN - 1442-200X

pISSN - 1328-8067

DOI - 10.1111/ped.13030

Subject(s) - medicine , lymphoma , peripheral blood stem cells , stem cell , transplantation , autologous stem cell transplantation , hematopoietic stem cell transplantation , evans syndrome , refractory (planetary science) , haematopoiesis , non hodgkin's lymphoma , peripheral blood , hodgkin lymphoma , surgery , immunology , antibody , physics , autoimmune hemolytic anemia , biology , astrobiology , genetics

There have been a number of recent reports on the occurrence of autoimmune conditions after autologous hematopoietic stem cell transplantation. We describe a rare case of Evans syndrome ( ES ) that developed in a 16‐year‐old patient >1 year after autologous peripheral blood stem cell transplantation for recurrent Hodgkin lymphoma. ES is a rare and frequently refractory condition. No therapy for the condition has been established, and it can often be fatal. In the present case, i.v. cyclosporine A injection was significantly effective against the ES , which has not recurred.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research